Submissions Open for the Cancer Moonshot Program
News Apr 19, 2016
The National Cancer Institute (NCI), part of the National Institutes of Health has launched an online platform to enable the research community and the public to submit ideas on the National Cancer Moonshot efforts. Submissions will be considered by the Blue Ribbon Panel (BRP) of scientific experts and patient advocates as they develop the scientific direction at NCI for the initiative.
The announcement of this online platform coincides with the opening of the American Association for Cancer Research (AACR) Annual Meeting in New Orleans. Ideas for advancing progress against cancer may be submitted at CancerResearchIdeas.cancer.gov.
The Blue Ribbon Panel, whose members were announced on April 4 and which held its first meeting on April 11, will serve as a working group of the presidentially appointed National Cancer Advisory Board (NCAB). One of the first actions of the panel was to discuss the establishment of several proposed working groups to focus on specific topic areas. Ideas, which may range from cancer prevention to advancing understanding of the origins of cancer to reducing cancer health disparities, may be submitted in the following areas:
- Cancer clinical trials
- Data sharing
- Dissemination and population sciences
- Immunotherapy, combination therapy, and immunoprevention
- Pediatric cancer
- Tumor evolution and progression
- Other exceptional opportunities
The ideas that are submitted will be discussed and considered by the proposed working groups and the Blue Ribbon Panel as they deliberate about cancer research priorities and opportunities over the next few months. The panel will report its findings to the NCAB later this summer.
“The goal of the Moonshot Initiative is to accelerate progress in the fight against cancer by swiftly advancing knowledge from cutting-edge basic research to new prevention and treatment strategies for patients,” said NCI Acting Director Douglas Lowy, M.D. “The community involvement that the initiative garners will allow us to consider novel, creative ideas that might not otherwise have come to NCI’s attention.”
Targeting Epigenetic Proteins to Prevent Breast CancerNews
Researchers have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study suggests that inhibiting these proteins with drugs could prevent the development of breast cancer in women at high risk of the disease.READ MORE
Chemists Design 'Mini-ecosystems' to Test Drug FunctionNews
Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.READ MORE
Targeting the Engine Room of the Cancer CellNews
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.READ MORE